Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm not worried. My deadline is a year + out and I was actually hoping this would stay at a reasonable price. I'm going to save a little powder in case the financials don't impress in November and buy some more.
Just trading wise, this came close to testing 8 and there may be some stop losses at 8. So be wary. For some odd reason it's been my experience that people put stops in at whole dollar amounts. I don't get that but so be it.
I'd at the very least core trade. Too many times I've exited out completely, only to miss a huge pop. I'm not selling any shares though and if anything, will cost average, even when averaging up.
You can see all the emotional traders' behavior during the day. And discipline in the market doesn't include emotion. How frustrated were we on Monday when we thought we were holding a bag. Then I uncovered that other company getting bought out, and I think I'm holding a bag of gold now.
It could've deflated some people it didn't pop like it could. But people know the Diaprim story and don't have a clear idea what the potential is with the greater picture. I think if it gapped up at a reasonable price it could've run a little but there were no shares for sale pre-market unless you were willing to pay in the 9's and the bids were all in the 7s. Then there were the large blocks in the AM on the ask that no one wanted to bite cause everyone's looking for cheap. Well.. It is cheap right now.
I think smart money has observed that this takes a dive at some point each day and they scoop up the lows from nervous traders. That's why volume always picks up in the dip and recovers pretty well. I'm actually hoping we stay in this range for a while and I can wait for some of my shorter term plays to pop so I can fatten my stash over here.
I'd like to hit 5000+ shares here without putting all my eggs in one basket. I think the financials in November might look weak from the expansion they just underwent. They just purchased 3 pharmacies in September for $499,000.
http://www.sec.gov/Archives/edgar/data/1360214/000149315215004558/form8-k.htm
But I think you'll see good earnings from that expansion in Q1 2016 after they complete the 503B facility. 2 nice catalysts to look forward to. If numbers are good at that time? A split would be nice, entirely possible with the small float. That's another catalyst. 2nd quarter earnings will reflect the 503B operations. Another catalyst. And remember that this will draw attention all year during 2016 elections with 3Q earnings coming out right at election time. Catalyst. At which point I only have to pay Uncle Sam 15% on whatever I sell. Patience is the reward and most folks are trying to sprint a marathon in the markets. I plan on going Buffet on IMMY. I used to only flip and trade and still do a little cause it's fun but the majority of my funds are in undervalued companies with huge upside. I'll wait for that "trade of a lifetime" that I hear people talk about but never seem to get it. Ya, know?
Always seems to recover after the dip. My shares are for sale for 1 million dollars if anyone wants them. They are also unavailable for borrowing and shorting. ;)
If we can break through that wall at 8.45 should see new 52 week high soon. We started slow yesterday too. I think a lot of people waiting on the sidelines for a bargain.
BOOOOM!!!! 503B FACILITY ANNOUNCED!!!!! $$$$
http://finance.yahoo.com/news/imprimis-pharmaceuticals-announces-plans-register-113500800.html
Why did an 800 pound gorilla pay out the nose to aquire a compounding pharmacy just before IPO?
PharMEDium, a compounding pharmacy company, was planning on going public to the tune of $100,000,000 and they were bought out for $2,575,000,000 in cash.
PharMEDium Healthcare Holdings was a company operating as a registered 503b pharmacy prior to its merger with AmerisourceBergen.
Big walls at 8.40 and 8.45.
Sorry meant *gagged.
T/A is not tagged either. They indicate in that presentation I posted earlier the total diluted outstanding which is 11,216,164 which still keeps this ridiculously low OS.
Big money just trying to shake the tree. They don't want to miss the train. I think the bulls move in tomorrow and Friday we really see what this has under the hood.
Winner winner chicken dinner! Let's go! IMMY
Wow! My gut said take out those 7.84's cause you might not get another chance. Glad I did!
An 8k was filed yesterday with the SEC for purposes of registering a new presentation the company will be using to market its technologies. It's fantastic. I strongly recommend looking it over.. This isn't a one-trick pony. I think we can use a lot of the information here for our intro.
http://www.sec.gov/Archives/edgar/data/1360214/000149315215005011/ex99-1.htm
Shares are going to be hard to get. There may be some that bought into the exuberance on Friday and if they don't have margin today is the first day they can sell. We're just consolidating. I really want to double down but want to see if there are any more weak hands that may get nervous today and tomorrow.
Looks like some are selling into the bid premarket. That's awesome. I was looking to buy more at 7.25. This may test 7 and if it breaks resistance, great opportunity to buy more.
Sellers have no clue the potential here.
Hang on to those shares with two hands.
So if anyone else is out there...
According to this article, IMMY is a 503a licensed pharmacy with plans to build a 503b facility.
http://www.bioworld.com/content/turing-pharma-ushers-rise-compounders-rx-alternatives
I thought, "WTF is the difference?" and the 503a operates on a much smaller scale like a corner drug store with limited human resources. 503b is a larger facility that can distribute larger quantities of compounds and ship them out
Then I thought, "Are there other companies trading publicly while operating an existing 503b compounding pharmacy?"
Google.. Google...
Holy crap! A compounding pharmacy filed with the SEC to go public? IPO and disruptive technology flying under the radar. PharMEDium is going public with the ticker PMHC!!! Woo hoo! Emerging market/disruptive technology/503b pharmacy and an early entry?
http://www.nasdaq.com/article/could-be-big-pharmedium-healthcare-files-for-a-100-million-ipo-cm515339
But alas, they were bought out before they could even go public for $2.6 billion dollars.
http://www.renaissancecapital.com/news/us-ipo-weekly-recap:-cut-the-offer-price-for-positive-returns-36766.html?utm_source=dlvr.it&utm_medium=stocktwits
IMMY has a market cap of $74.55 million dollars. I thought, "lets's divide the buyout price of a company with a 503b licensed operation by the current market cap of IMMY for a pps multiplier of things to come once the 503b facility is built."
2,600,000,000 / 74,550,000 and
34.88 is the multiplier. Anyone's welcomed to check my math.
Multiplier of 34.88 X the current pps of 7.77 = $277.01 per share.
Call me crazy but that's my target price.
And I determined that compounding pharmacies are a disruptive entity and tiny little secret in biotech because 800 pound gorillas are willing to gobble them up and keep this secret in the dark.
Good luck all! Like I said, only paying 15% tax on these shares.
You out, my friend or are you hanging in there?
Wasn't sure how low this was going and was watching to load more at 7.25. Looks like a lot of stubborn hands holding on to their shares. Good! Forming a solid base.
Volume before price.
I think the next 2 days are going to be tricky. And if anyone is thinking about buying in or cost averaging, there may be opportunity tomorrow and Wednesday. Tomorrow I think you'll see 3 day traders taking profit before Wednesday when the folks without margin have an opportunity to exit if they bought high on Friday. This is going to be a little volatile. Just observing this the past 2 days, seems to be large blocks taking the pps down dramtically at least twice a day causing weak hands and nervous traders to bail, creating a freefall. The pps then recovers shortly after. Tomorrow and Wednesday will see similar movements, while larger entities try to accrue shares while they can. Thursday this should level out when shares are in the hands of bulls going long and I think you want to have your position firm by then.
The arguement for rapidly rising pharmaceutical treatments has always been that free enterprise and the market will work out the problem. But while the prices of drugs have gone up there has been no market solution.. Until now. So, there lies the real optimism regarding IMMY. I believe the healthcare sector is recovering partly because this is such positive news.
Again, a huge volume day, so almost half the entire float has changed hands in 2 days and those shares will eventually fall in the hands of people that are not trying to beat the system and trade frequently, but move with the overall market sentiment over time. I think after Thursday, steady climb north once the emotional traders are gone. All my opinion, and, as always, do your own due dilligence and stay positive.
Me, personally? I really only want to pay 15% tax on these shares. GL!
Love a small float! I'll be holding my shares.
Feeling good. I wanted to pick more this morning. Walked away for 30 minutes and boom! Into the 8s. Oh well. I'm holding. The amount of shares that have traded the past two days should give it some stability for a while. We shall see. Good luck! Lots of interest here.
How ya feelin,? ;)
Thanks for updating the intro!
I'm planning on buying a few more shares but with a little more discipline than I had on Friday. They've a 52 week high of 9 so I think cost averaging below 8 for awhile is ok. If it breaks above 9 for a new high, I'll just sit on my shares and watch how she goes. Good luck!
I guess it depends on trading strategy and foresight as far as expectations go with the compounding pharmacy industry. If someone is trading this, then I could recognize the Diaprim alternative announcement as a "pump". But then there are traders and then there are investors; 2 different animals.
I think Mark Baum and Imprimis is seizing an opportunity to answer an unmet need to offer a compound based on a generic drug's active ingredient and deliver it to the patient at an affordable cost. Their operations are highly regulated and have to meet strict standards but Imprimis is a pharmacy, so they have the ability to turn the prescriptions out quickly. Baum recently stated they are creating a program called "Imprimis Cares" to identify other generic drugs that have become unaffordable due to price gouging. I've read that they have been inundated with calls from doctors and nurses suggesting other compounds to meet the patients needs and bring their patients' healthcare costs down.
I broke one of my trading rules - never rush in until after 10:15 - 10:45 when the houses are done closing short positions. And I think this suffered a bear raid so that bigger money can grab as many shares as possible at lower prices, hence the pps recovery late in the day. I'm in at 7.75 so I feel you.
However, if this is a white knight / disruptive technology storyline that can be expanded to meet more and more patient needs, This is a buy and hold through the 2016 elections considering how few shares are available and affordable prescription drugs are an issue that affects a large part of the population. Tiny floats are sometimes epic. Most people were not made aware of the story until late Friday when larger publications began running the piece. Every story I read has to explain in detail how a compounding pharmacy operates, so this could be in its infancy even though they are operating like a 1950's apothecary with a mortar and pestle - but on a larger scale.
This thing is just getting started. I am stoked for this company. Articles in Forbes, Wall Street Journal, all major outlets. Loving it.
http://www.wsj.com/articles/defeated-by-the-99-cent-drug-store-1445639504
Tiny float and a disruptive answer to the most hated scum in biotech.
I like the fact that he has to cover the $55 million he paid for Daraprim while competing with a compounding pharmacy. Seems that the compounding pharmaceutical industry is going to get a lot of attention over the next year.
You would think but that other one is a cult of personality. It defies common sense.
Sounds like your brokerage firm is milking commisions. Note to self: avoid Charles Schwab.
GL to you as well. I hope everyone here makes a profit. They'll work out the kinks. Could be big. Stay positive!
It's available on my iPhone app store. It is not available on my iPad app store.
Not sure what to say about that except I bought the hype and sold the story. Sorry guys. If they're having trouble rolling out a clean product on all platforms, I'll wait for a finished product.
I think the problem with the MJ sector is that there remains a "high frequecy trader" element that seem to hang on to the belief that there will be a stock that truly breaks out and immediate profits are conceived in the MJ sector.
There are other stocks that run every day but they thrive in sectors with volume. This sector has no volume so day traders focused on MJ stocks, following bread crumb trails are fighting over scraps creating volatility and stocks that may be worth their merit have trouble finding a base. KAYS is stuck in this war where the longs believe their shares are worth at least .08 and traders are just looking to flip on the 'buy the hype sell the story BS'. Everybody's on to it. It does't work anymore unless there is crazy volume. Markets evolve. I took a gamble and made 40%'on that Weight Watchers baloney because there was huge volume.
I think there will be a shift in strategy in this sector in the next 3 to 6 months where investors will settle in for longer plays and realize the flip is futile compared to a slow burn. My trading strategy has shifted dramatically over a year of watching this sector. It will pop eventually.
This is what I don't understand regarding the sentiment of both companies. With Kaya Holdings, they have been delivering results consistent with a very organized and methodical business plan that doesn't overreach. They don't pump false press releases that set high expectations and fail. KAYS doesn't get the love of the market. I'm bewildered by it but it's to any long's advantage because it's kept the pps undervalued and ridiculously affordable for those with a little patience and foresight.
Hence the speculation of a brick & mortar store expanding in the state of Oregon, with the expectation of growth in the company based on an increase of sales due to a catalyst like the sale of recreational cannabis.